These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16991122)

  • 1. Urinary biomarker profiling in transitional cell carcinoma.
    Munro NP; Cairns DA; Clarke P; Rogers M; Stanley AJ; Barrett JH; Harnden P; Thompson D; Eardley I; Banks RE; Knowles MA
    Int J Cancer; 2006 Dec; 119(11):2642-50. PubMed ID: 16991122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tree analysis pattern of mass spectral urine profiles in differential diagnosis of bladder transitional cell carcinoma].
    Wu DL; Zhang YF; Guan M; Liu WW; Xu YM; Jin SB; Zhang J; Jin CR; Lü Y
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):274-7. PubMed ID: 17760254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.
    Vlahou A; Schellhammer PF; Mendrinos S; Patel K; Kondylis FI; Gong L; Nasim S; Wright GL
    Am J Pathol; 2001 Apr; 158(4):1491-502. PubMed ID: 11290567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal fibronectin: a new screening-marker for bladder cancer?
    Wunderlich H; Reichelt O; Zermann DH; Schubert J; Berndt A; Kosmehl H
    Oncol Rep; 2001; 8(3):669-72. PubMed ID: 11295100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient.
    Zhang YF; Wu DL; Guan M; Liu WW; Wu Z; Chen YM; Zhang WZ; Lu Y
    Clin Biochem; 2004 Sep; 37(9):772-9. PubMed ID: 15329315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the NMP22 test and comparison with voided urine cytology in the detection of bladder cancer.
    Lee KH
    Yonsei Med J; 2001 Feb; 42(1):14-8. PubMed ID: 11293494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary cytokeratin 20 as a marker for transitional cell carcinoma.
    Rotem D; Cassel A; Lindenfeld N; Mecz Y; Sova Y; Resnick M; Stein A
    Eur Urol; 2000 May; 37(5):601-4. PubMed ID: 10765100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
    Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder.
    Jamshidian H; Kor K; Djalali M
    Urol J; 2008; 5(4):243-7. PubMed ID: 19101898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine laminin P1 assessment discriminates between invasive and noninvasive urothelial cell carcinoma of the bladder.
    Abou Farha KM; Menheere PP; Nieman FH; Janknegt RA; Arends JW
    Urol Int; 1993; 51(4):204-8. PubMed ID: 8266611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
    Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
    Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of hepatoma-up-regulated protein expression in patients with urinary bladder transitional cell carcinoma.
    Huang YL; Chiu AW; Huan SK; Wang YC; Ju JP; Lu CL
    Anticancer Res; 2003; 23(3B):2729-33. PubMed ID: 12894566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity and specificity of urinary hyaluronic acid and hyaluronidase in detection of bladder transitional cell carcinoma.
    Jamshidian H; Hashemi M; Nowroozi MR; Ayati M; Bonyadi M; Najjaran Tousi V
    Urol J; 2014 Mar; 11(1):1232-7. PubMed ID: 24595930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma.
    Passerotti CC; Srougi M; Bomfim AC; Martins JR; Leite KR; Dos Reis ST; Sampaio LO; Ortiz V; Dietrich CP; Nader HB
    Urol Oncol; 2011; 29(6):710-5. PubMed ID: 19962919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder.
    Shariat SF; Matsumoto K; Casella R; Jian W; Lerner SP
    Eur Urol; 2005 Jul; 48(1):69-76. PubMed ID: 15967254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.
    Svatek RS; Herman MP; Lotan Y; Casella R; Hsieh JT; Sagalowsky AI; Shariat SF
    Cancer; 2006 Apr; 106(8):1701-7. PubMed ID: 16541433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder.
    Korman HJ; Peabody JO; Cerny JC; Farah RN; Yao J; Raz A
    J Urol; 1996 Jan; 155(1):347-9. PubMed ID: 7490884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of autocrine motility factor in urine as a marker of bladder cancer.
    Guirguis R; Schiffmann E; Liu B; Birkbeck D; Engel J; Liotta L
    J Natl Cancer Inst; 1988 Oct; 80(15):1203-11. PubMed ID: 3138430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology.
    Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X
    Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
    Shariat SF; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Sawczuk I; Serretta V; Huland H; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Wians F; Roehrborn CG; Lotan Y; Perrotte P; Benayoun S; Marberger MJ; Karakiewicz PI
    J Urol; 2005 May; 173(5):1518-25. PubMed ID: 15821471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.